Chapman Peter Hume

Executive Chair Peter Hume sold 1,497,311 shares (79.3% of holdings) for $59.8M at $39.93 on 2025-06-20

Chapman Peter Hume, Executive Chair, divested 1,497,311 shares (-79.3% vs pre-transaction holdings), reducing his stake from 1,887,640 shares to 390,329 shares. This represents a substantial reduction in personal exposure to IonQ at a price ($39.93) that sits -21.0% from the 52-week high of $51.07. While the company has achieved strong revenue growth of +95.4% year-over-year, it remains deeply unprofitable with a net loss of $-32,252,000 on quarterly revenue of $7,566,000, underscoring cash burn concerns. The timing merits attention: across his cross-ticker track record, Hume's prior sells have averaged a 90d well-timed rate of 50.00%, while his same-ticker history at IONQ shows mixed results—a prior sell on 2025-03-11 was followed by +114.0% 90d return (poorly timed), but a 2023-12-11 sell preceded an -18.2% decline (well-timed). The recent rapid share sales (three transactions in four trading days: 2025-06-16, 06-17, and 06-20) suggest discretionary execution unfolding in a compressed window.

Chapman Peter Hume (Chair) sold 4,491,933 shares for $170,943,137.56 over 2 days (June 16–17), reducing holdings 92.0%

Chapman Peter Hume executed 2 separate sales totaling 4,491,933 shares for $170,943,137.56 over June 16–17, 2025, reducing his holdings from 4.88M to 390.3K shares (a 92.0% reduction of pre-transaction holdings). The blended average sale price of $38.06 sits 3.9% below the current price of $39.63, while IonQ's stock has risen 12.9% over 30 days and 87.5% over 90 days following a sharp recovery from its 52-week low of $6.57. His prior 2 sales at IONQ show mixed timing: a March 2025 sale preceded a 114.0% 90-day gain (poorly timed), while a December 2023 sale preceded an 18.2% 90-day decline (well-timed). Against this company backdrop—$7.6M quarterly revenue, negative $32.3M net income, and unprofitability over the full fiscal year—the concentration and magnitude of this insider liquidation warrants attention to whether it signals a fundamental reassessment of IonQ's growth trajectory or reflects personal financial rebalancing.

Chapman Peter Hume (Executive Chair) sold 2,000,000 shares of IONQ at $18.72 on 2025-03-11 for $37,446,600.00, reducing holdings by 82.8%.

Chapman Peter Hume sold 2,000,000 shares (2.00M shares) representing 82.8% of his pre-transaction holdings, retaining only 414,363 shares (414.4K shares), a dramatic reduction in executive ownership of an unprofitable growth-stage company. The timing occurs during significant stock weakness: the stock is -63.4% from its 52-week high of $51.07, down -53.9% over the past 30 days, and -37.3% over 90 days. IONQ's fundamentals show quarterly revenue of $12,400,000.00 ($12.4M) with annual revenue growth of +95.4%, but the company is deeply unprofitable with a net loss of $52,496,000.00 ($-52.5M) over the most recent full fiscal year. His prior sale at this ticker in December 2023 proved well-timed, with a 90-day negative return of -18.2% following that sale. The near-complete liquidation of a founder-level executive's stake, combined with the company's sustained losses despite strong top-line growth and the recent price collapse, signals a material shift in his capital allocation away from this investment.